xmlns:atom="http://www.w3.org/2005/Atom" xmlns:atom="http://www.w3.org/2005/Atom"
Regulation 2(1)
Extent Information
E1This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only for the substitution of Sch. 2 in relation to E.W.S. (31.12.2020) by The Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/791), regs. 1(1), 9(10) (as amended by S.I. 2020/1478, regs. 1(3), Sch. 2 para. 2); 2020 c. 1, Sch. 5 para. 1(1)
1. The agreement on mutual recognition in relation to conformity assessment certificates and markings between the European Community and Australia, initialled on 19th July 1996 M1.N.I.
Marginal Citations
M1OJ No. L 229, 17.8.1998, p.3.
2. The agreement on mutual recognition in relation to conformity assessment between the European Union and New Zealand, initialled on 19th July 1996 M2.N.I.
Marginal Citations
M2OJ No. L 229, 17.8.1998, p.62.
3. The agreement on mutual recognition between the European Community and Canada, signed in London on 14th May 1998 M3.N.I.
Marginal Citations
M3OJ No. L 280, 16.10.1998, p.3.
4. The agreement on mutual recognition between the European Community and the United States of America, signed in London on 18th May 1998 M4.N.I.
Marginal Citations
M4OJ No. L 31, 4.2.1999, p.3.
[F15. The agreement between the European Community and the Swiss Confederation on mutual recognition in relation to conformity assessment signed in Luxembourg on 21st June 1999.]U.K.
Textual Amendments
F1Sch. 2 para. 5 added (21.10.2013) by The Medical Devices (Amendment) Regulations 2013 (S.I. 2013/2327), regs. 1(2), 20